Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Teva_Pharmaceutical_Industries
|
| gptkbp:acquisitionYear |
2000
|
| gptkbp:CEO |
gptkb:Christine_Poulin
|
| gptkbp:country |
gptkb:Canada
|
| gptkbp:formerName |
gptkb:Novopharm_Limited
|
| gptkbp:foundedYear |
1965
|
| gptkbp:headquartersLocation |
gptkb:Toronto
|
| https://www.w3.org/2000/01/rdf-schema#label |
Teva Canada Limited
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:market |
gptkb:Canada
|
| gptkbp:numberOfEmployees |
over 1,000
|
| gptkbp:parentCompany |
gptkb:Teva_Pharmaceutical_Industries
|
| gptkbp:products |
generic drugs
branded pharmaceuticals |
| gptkbp:website |
https://www.tevacanada.com/
|
| gptkbp:bfsParent |
gptkb:Teva_Pharmaceutical_Industries
|
| gptkbp:bfsLayer |
5
|